S. Bondock, A. E-G Tarhoni, and A. A. Fadda
Vol 000
Anal. Calcd for C18H14N2O4S (354.38): C 61.01; H 3.98; N 7.90%,
Found: C 61.24; H 3.83; N 7.86%.
(19.7), 203 (24.9), 175 (46.6) 173 (100), 160 (14.8), 145 (28.3),
77 (19.9), 51(28.8). Anal. Calcd for C19H12N2O3S (348.38): C
7,7-Dimethyl-2,5-dioxo-N-(4-phenylthiazol-2-yl)-5,6,7,8-
tetrahydro-2H-chromene-3-carboxamide (6). This compound
was prepared from dimedone (0.14) by heating for 10 h under
65.51; H 3.47; N 8.04%, found: C 65.34; H 3.43; N 8.20%.
7-Hydroxy-2-oxo-N-(4-phenylthiazol-2-yl)-2H-chromene-3-
carboxamide (14). This compound was prepared from resorcinol
(0.11 g) by heating for 15 h under reflux and recrystallized from a
mixture of ethanol and dimethylformamide (1:1).
reflux and recrystallized from
a mixture of ethanol and
dimethylformamide (1:1).
Brown powdered; yield 62%; mp 287–288ꢁC; IR (KBr): vmax.
/
Pale yellow crystal; Yield 55%; mp 279–280ꢁC; IR (KBr): vmax.
/
cmÀ1 = 3450 (OH), 3365 (NH),1719 (cyclic ester), 1658 (amidic
C═O). 1H NMR (DMSO–d6): dppm = 6.81 (s, 1H, chromene
H-8), 6.94 (d, J = 5.6 Hz, 1H, chromene H-5), 7.65 (d, J = 5.6 Hz,
1H, chromene H-6), 7.28–7.77 (m, 9H, Ar-H),7.52 (s, 1H, thiazole
H-5), 8.48 (s, 1H, chromene H-4), 10.41 (s, br, 1H, NH), 13.04
(s, br, 1H, OH). MS m/z (%): 364 (M+, 31.8), 320 (39.7), 287
(19.7), 203 (45.3), 189 (100), 175 (18.3), 160 (26.3), 77 (28.3),
58 (20.3). Anal. Calcd for C19H12N2O4S (364.37): C 62.63; H
3.32; N 7.69%, found: C 62.42; H 3.43; N 7.52%.
cmÀ1 = 3380 (NH), 1720 (cyclic ester), 1665 (cyclic C═O), 1655
1
(amidic C═O). H NMR (DMSO–d6): dppm = 1.21 (s, 3H, CH3),
1.23 (s, 3H, CH3), 2.42 (s, 2H, chromene 8-CH2), 2.68 (s, 2H,
chromene 6-CH2), 7.29–7.96 (m, 5H, Ar-H), 7.57 (s, 1H, thiazole
H-5), 8.73 (s, 1H, chromene H-4), 12.85 (s, br, 1H, NH). MS m/z
(%): 394 (M+, 36.5), 350 (19.6), 324 (30.2), 252 (26.3), 229
(33.2), 220 (46.6), 203 (16.3), 191 (100), 175 (34.6), 160 (15.8),
123 (21.4), 77 (23.6), 58 (18.3). Anal. Calcd for C21H18N2O4S
(394.44): C 63.94; H 4.60; N 7.10%, found: C 64.04; H 4.51;
2-Oxo-N-(4-phenylthiazol-2-yl)-2H-benzo[h]chromene-3-
carboxamide (16). This compound was prepared from a-naphthol
(0.144 g) by heating for 16 h under reflux and recrystallized from a
mixture of ethanol and dimethylformamide (1:1).
N 7.02%.
4-Cyano-1-oxo-N-(4-phenylthiazol-2-yl)-1H-pyrido[2,1-b]
benzothiazole-2-carboxamide (8). This compound was prepared
from (benzothiazol-2-yl)acetonitrile (0.174 g) by heating for 10h
under reflux and recrystallized from a mixture of ethanol and
dimethylformamide (1:1).
Deep brown powdered; yield 59%; mp 298–299ꢁC; IR (KBr):
vmax./cmÀ1 = 3368 (NH), 1728 (cyclic ester), 1661 (amidic C═O).
1H NMR (DMSO–d6): dppm = 7.29–8.02 (m, 9H, Ar-H), 7.52 (s,
1H, thiazole H-5), 7.77 (d, J = 4.8 Hz, 1H, benzochromene H-5),
8.50 (d, J = 4.8 Hz, 1H, benzochromene H-6), 8.81 (s, 1H, benzo-
chromene H-4), 11.12 (s, br, 1H, NH). 13C NMR (DMSO–d6):
Brown powdered; yield 54%; mp 281–282ꢁC; IR (KBr): vmax.
/
cmÀ1 = 3360 (NH), 2219 (CꢀN), 1695, 1656 (2 amidic C═O).
1H NMR (DMSO–d6): dppm = 6.9–7.96 (m, 9H, Ar-H), 7.49
(s, 1H, thiazole H-5), 8.72 (s, 1H, pyridobenzothiazole H-3),
12.71 (s, br, 1H, NH). MS m/z (%): 428 (M+, 39.7), 376 (27.8),
320 (19.2), 253 (26.9), 225 (43.3), 203 (28.4), 175 (34.6), 160
(100), 134 (53.3), 77 (33.8), 58 (17.3). Anal. Calcd for
C22H12N4O2S2 (428.49): C 61.67; H 2.82; N 13.08%, found: C
d
ppm = 105.5 (thiazole C-5), 117.5 (benzopyran C-3), 119.3,
120.8, 121.6, 123.3, 125.3, 125.5, 126.2, 127.3, 127.7, 128.3,
128.8, 129.3, 131.0, 131.1, 133.6 (CHAr + CAr), 150.5 (thiazole C-
4), 155.1 (thiazole C-2), 158.4 (CONH), 165.4 (benzopyran
C═O). MS m/z (%): 398 (M+, 24.3), 354 (33.5), 223 (100), 203
(31.3), 195 (36.6), 175 (29.9), 160 (21.3), 152 (24.8), 77 (30.4),
58 (18.6). Anal. Calcd for C23H14N2O3S (398.43): C 69.33; H
61.48; H 2.91; N 13.22%.
4-Cyano-1-oxo-N-(4-phenylthiazol-2-yl)-1,5-dihydropyrido
[1,2a]benzimidazole-2-carboxamide (10). This compound was
prepared from (benzimidazol-2-yl)acetonitrile (0.157g) by heating
for 12h under reflux and recrystallized from a mixture of ethanol
and dimethylformamide (1:1).
3.54; N 7.03%, found: C 69.24; H 3.62; N 7.19%.
3-Oxo-N-(4-phenylthiazol-2-yl)-3H-benzo[f]chromene-2-
carboxamide (18). This compound was prepared from b-naphthol
(0.144 g) by heating for 16 h under reflux and recrystallized from a
mixture of ethanol and dimethylformamide (1:1).
Yellowish brown powdered; yield 56%; mp 293–294ꢁC; IR
(KBr): vmax./cmÀ1 = 3410–3378 (2NH), 2215 (CꢀN), 1690, 1658
(2 amidic C═O). 1H NMR (DMSO–d6): dppm = 7.05–7.96 (m,
9H, Ar-H), 7.49 (s, 1H, thiazole H-5), 8.75 (s, 1H, pyridobenzimi-
dazole H-3), 9.18 (s, br, 1H, NH), 12.79 (s, br, 1H, NH). MS m/z
(%): 411(M+, 33.9), 383 (23.3), 336 (20.2), 258 (29.7), 236
(19.8), 208 (100), 203 (36.6), 175 (20.3), 160 (23.1), 133 (50.2),
77 (27.9), 54 (16.7). Anal. Calcd for C22H13N5O2S (411.44): C
64.22; H 3.18; N 17.02%, found: C 64.04; H 3.23; N 17.14%.
2-Oxo-N-(4-phenylthiazol-2-yl)-2H-chromene-3-carboxamide
Reddish brown powdered; yield 82%; mp > 300ꢁC; IR (KBr):
vmax./cmÀ1 = 3362 (NH), 1726 (cyclic ester), 1659 (amidic C═O).
1H NMR (DMSO–d6): dppm = 7.87–8.01 (m, 9H, Ar-H), 7.52
(s, 1H, thiazole H-5), 7.64 (d, J = 4.6 Hz, 1H, benzochromene
H-5), 8.38 (d, J = 4.6 Hz, 1H, benzochromene H-6), 9.92
(s, 1H, benzochromene H-1), 11.22 (s, br, 1H, NH). Anal. Calcd
for C23H14N2O3S (398.43): C 69.33; H 3.54; N 7.03%, found:
C 69.56; H 3.44; N 7.11%.
(12).
This compound was prepared from phenol (0.094 g) by
6-Oxo-3-phenyl-N-(4-phenylthiazol-2-yl)-6H-pyrano[3,2-d]
isoxazole-5-carboxamide (20). This compound was prepared
from 3-phenylisoxazol-5-one (0.161 g) by heating for 6 h under
reflux and recrystallized from a mixture of ethanol and
dimethylformamide (1:1).
heating for 48 h under reflux and recrystallized from a mixture of
methanol and dimethylformamide (1:1).
Alternative method for the synthesis of compound 12. A
mixture of compound 1 (0.243 g, 0.001 mol) and salicylaldehyde
(0.122 g, 0.001 mol) in ethanol (30 mL) containing a little amount of
piperidine (3 drops) was refluxed for 3 h. The reaction mixture was
allowed to cool to room temperature and then pour onto ice cold
water (25 mL) containing few drops of conc. HCl. The precipitated
product was filtered off, dried well, and crystallized from a mixture of
Yellow powdered; yield 62%; mp 275–276ꢁC; IR (KBr): vma1x.
/
cmÀ1 = 3372 (NH), 1724 (cyclic ester), 1671 (amidic C═O). H
NMR (DMSO–d6): dppm = 6.98–7.87 (m, 10H, Ar-H), 7.52
(s, 1H, thiazole H-5), 8.89 (s, 1H, pyranoisoxazole H-4), 12.51
(s, br, 1H, NH). MS m/z (%): 415 (M+, 35.7), 371(50.6), 240
(26.6), 212 (100), 203 (54.4), 175 (36.3), 160 (17.8), 77 (18.3),
58 (22.3). Anal. Calcd for C22H13N3O4S (415.42): C 63.61; H
methanol and dimethylformamide (1:1) to give compound 12.
Pale yellow crystals; yield 48%; mp 269–270ꢁC; IR (KBr):
vmax./cmÀ1 = 3378 (NH), 1725 (cyclic easter), 1657 (amidic
3.15; N 10.12%, found: C 63.44; H 3.23; N 10.21%.
1
3-Methyl-6-oxo-1-phenyl-N-(4-phenylthiazol-2-yl)-1,6-
C═O). H NMR (DMSO–d6): dppm = 7.13–7.79 (m, 9H, Ar-H),
dihydropyrano [2,3-c]pyrazole-5-carboxamide (22). This
compound was prepared from 3-methyl-1-phenyl-1H-pyrazol-5
7.52 (s, 1H, thiazole H-5), 8.43 (s, 1H, chromene H-4), 10.68
(s, br, 1H, NH). MS m/z (%): 348 (M+, 40.1), 304 (49.2), 271
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet.1677